LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes

Overview of attention for article published in Leukemia Research, March 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent: 8 patents

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

LFA-1 signaling mediator for use in cancer therapy

Application JP-2023538568-A

Japan

08 Sep 2023

Method of treating autoimmune inflammatory crohn's disease

Grant US-11612636-B2

United States of America

28 Mar 2023

Treatment and diagnosis of inflammatory disorders and HIV

Grant US-10993989-B2

United States of America

04 May 2021

Treatment and diagnosis of inflammatory disorders and HIV

Grant US-10603354-B2

United States of America

31 Mar 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.